Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciying Qian

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Science China. Life Sciences|December 5, 2022
Current progress in the development of prophylactic and therapeutic vaccinesTingting Li, Ciying Qian, Ying Gu, et al.
International Journal of Biological Macromolecules|June 26, 2025
Advancing mRNA vaccines: A comprehensive review of design, delivery, and efficacy in infectious diseasesYihan Lu, Ciying Qian, Yang Huang, et al.
Vaccines|April 5, 2020
Recent Progress on the Versatility of Virus-Like ParticlesCiying Qian, Xinlin Liu, Qin Xu, et al.
Vaccine|August 31, 2024
Characterization of a triple-type chimeric vaccine against human papillomavirus types 18, 45, and 59Xin Chi, Feng Han, Yanan Jiang, et al.
Emerging Microbes & Infections|November 27, 2019
Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infectionXinlin Liu, Jie Chen, Zhiping Wang, et al.
Vaccine|September 18, 2022
A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26Miao Yu, Xin Chi, Shiwen Huang, et al.
Iscience|September 29, 2025
Multi-epitope transplantation enables cross-type neutralization of phylogenetically distant HPV11/6/53 in miceCiying Qian, Yujie Xu, Yang Huang, et al.
Journal of Virology|February 23, 2023
Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16Jie Chen, Daning Wang, Zhiping Wang, et al.
Journal of Nanobiotechnology|January 19, 2025
Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sitesCiying Qian, Jie Chen, Yurou Yang, et al.
Science Bulletin|December 30, 2023
Rational design of a cross-type HPV vaccine through immunodominance shift guided by a cross-neutralizing antibodyZhiping Wang, Daning Wang, Jie Chen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Science China. Life Sciences|December 5, 2022
Current progress in the development of prophylactic and therapeutic vaccinesTingting Li, Ciying Qian, Ying Gu, et al.
International Journal of Biological Macromolecules|June 26, 2025
Advancing mRNA vaccines: A comprehensive review of design, delivery, and efficacy in infectious diseasesYihan Lu, Ciying Qian, Yang Huang, et al.
Vaccines|April 5, 2020
Recent Progress on the Versatility of Virus-Like ParticlesCiying Qian, Xinlin Liu, Qin Xu, et al.
Vaccine|August 31, 2024
Characterization of a triple-type chimeric vaccine against human papillomavirus types 18, 45, and 59Xin Chi, Feng Han, Yanan Jiang, et al.
Emerging Microbes & Infections|November 27, 2019
Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infectionXinlin Liu, Jie Chen, Zhiping Wang, et al.
Vaccine|September 18, 2022
A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26Miao Yu, Xin Chi, Shiwen Huang, et al.
Iscience|September 29, 2025
Multi-epitope transplantation enables cross-type neutralization of phylogenetically distant HPV11/6/53 in miceCiying Qian, Yujie Xu, Yang Huang, et al.
Journal of Virology|February 23, 2023
Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16Jie Chen, Daning Wang, Zhiping Wang, et al.
Journal of Nanobiotechnology|January 19, 2025
Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sitesCiying Qian, Jie Chen, Yurou Yang, et al.
Science Bulletin|December 30, 2023
Rational design of a cross-type HPV vaccine through immunodominance shift guided by a cross-neutralizing antibodyZhiping Wang, Daning Wang, Jie Chen, et al.
Pageof 2